Emerging Neuroblastoma 3D In Vitro Models for Pre-Clinical Assessments
The potential of tumor three-dimensional (3D) in vitro models for the validation of existing or novel anti-cancer therapies has been largely recognized. During the last decade, diverse in vitro 3D cell systems have been proposed as a bridging link between two-dimensional (2D) cell cultures and in vi...
Main Authors: | Diana Corallo, Stella Frabetti, Olivia Candini, Elisa Gregianin, Massimo Dominici, Horst Fischer, Sanja Aveic |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-11-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.584214/full |
Similar Items
-
CAR T Cell Therapy for Neuroblastoma
by: Rebecca M. Richards, et al.
Published: (2018-10-01) -
Neuroblastoma of the Urinary Bladder in an Infant
by: Ahmed Mohamed, et al.
Published: (2019-01-01) -
Neuroblastoma: Tumor Biology and Its Implications for Staging and Treatment
by: Kyle J. Van Arendonk, et al.
Published: (2019-01-01) -
Strategies to Improve Chimeric Antigen Receptor Therapies for Neuroblastoma
by: Piamsiri Sawaisorn, et al.
Published: (2020-12-01) -
Primary pancreatic neuroblastoma presenting with opsoclonus–myoclonus syndrome
by: Samuel Galgano, MD, et al.
Published: (2016-03-01)